Acute Haemodynamic Impact of an IV Glucose-Injection

This study has been withdrawn prior to enrollment.
Sponsor:
Information provided by:
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT00426114
First received: January 23, 2007
Last updated: April 9, 2009
Last verified: April 2009
  Purpose

Patients with peritoneal dialysis will be administered an IV glucose-injection to evaluate the haemodynamic impact of this injection. The patients will be matched with healthy volunteers.


Condition Intervention Phase
Peritoneal Dialysis
Drug: Administration of an IV glucose-injection
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Acute Haemodynamic Impact of an IV Glucose-Injection

Resource links provided by NLM:


Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • Haemodynamic parameters
  • Glycemia

Estimated Enrollment: 20
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • > 18 years old
  • Stable clinical condition
  • Either peritoneal dialysis (at least one month) either matched healthy subject

Exclusion Criteria:

  • Heart Failure
  • Diabetes requiring insulin treatment
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00426114

Sponsors and Collaborators
University Hospital, Ghent
Investigators
Principal Investigator: Wim Van Biesen, MD, PhD University Hospital, Ghent
  More Information

Additional Information:
No publications provided

Responsible Party: Wim Van Biesen, University Hospital Ghent
ClinicalTrials.gov Identifier: NCT00426114     History of Changes
Other Study ID Numbers: 2007/016
Study First Received: January 23, 2007
Last Updated: April 9, 2009
Health Authority: Belgium: Federal Agency for Medicinal Products and Health Products

ClinicalTrials.gov processed this record on August 27, 2014